RS51051B - Heksaciklična jedinjenja - Google Patents

Heksaciklična jedinjenja

Info

Publication number
RS51051B
RS51051B YUP-470/04A YUP47004A RS51051B RS 51051 B RS51051 B RS 51051B YU P47004 A YUP47004 A YU P47004A RS 51051 B RS51051 B RS 51051B
Authority
RS
Serbia
Prior art keywords
ethyl
hydroxy
pyrano
pyrido
quinazoline
Prior art date
Application number
YUP-470/04A
Other languages
English (en)
Serbian (sr)
Inventor
Takeshi Murata
Satoshi Niizuma
Nobuo Shimma
Hitomi Suda
Masao Tsukazaki
Original Assignee
Chugai Seiyaku Kabushiki Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Seiyaku Kabushiki Kaisha filed Critical Chugai Seiyaku Kabushiki Kaisha
Publication of RS47004A publication Critical patent/RS47004A/sr
Publication of RS51051B publication Critical patent/RS51051B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
YUP-470/04A 2001-11-30 2002-11-25 Heksaciklična jedinjenja RS51051B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01128361 2001-11-30
PCT/EP2002/013216 WO2003045952A2 (en) 2001-11-30 2002-11-25 Condensed camptothecins as antitumor agents

Publications (2)

Publication Number Publication Date
RS47004A RS47004A (sr) 2007-02-05
RS51051B true RS51051B (sr) 2010-10-31

Family

ID=8179394

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-470/04A RS51051B (sr) 2001-11-30 2002-11-25 Heksaciklična jedinjenja

Country Status (28)

Country Link
US (2) US6825194B2 (OSRAM)
EP (1) EP1480984B9 (OSRAM)
JP (1) JP4305909B2 (OSRAM)
KR (1) KR100895746B1 (OSRAM)
CN (1) CN100338066C (OSRAM)
AT (1) ATE398131T1 (OSRAM)
AU (1) AU2002356720B2 (OSRAM)
BR (1) BR0214615A (OSRAM)
CA (1) CA2468824C (OSRAM)
DE (1) DE60227113D1 (OSRAM)
ES (1) ES2307830T3 (OSRAM)
GT (1) GT200200250A (OSRAM)
HU (1) HUP0500062A3 (OSRAM)
IL (1) IL162058A0 (OSRAM)
MX (1) MXPA04005185A (OSRAM)
MY (1) MY136138A (OSRAM)
NO (1) NO329005B1 (OSRAM)
NZ (1) NZ533568A (OSRAM)
PA (1) PA8558901A1 (OSRAM)
PE (1) PE20030725A1 (OSRAM)
PL (1) PL207510B1 (OSRAM)
RS (1) RS51051B (OSRAM)
RU (1) RU2299212C2 (OSRAM)
TW (1) TWI258481B (OSRAM)
UA (1) UA80409C2 (OSRAM)
UY (1) UY27560A1 (OSRAM)
WO (1) WO2003045952A2 (OSRAM)
ZA (1) ZA200404522B (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1777611A (zh) * 2003-02-21 2006-05-24 中外制药株式会社 制备六环喜树碱衍生物的方法
MXPA06011679A (es) 2004-04-09 2007-01-23 Chugai Pharmaceutical Co Ltd Novedosos profarmacos solubles en agua.
TW200744603A (en) * 2005-08-22 2007-12-16 Chugai Pharmaceutical Co Ltd Novel anticancer concomitant drug
US20090118271A1 (en) * 2005-10-19 2009-05-07 Chugai Seiyaku Kabushiki Kaisha Preventive or Therapeutic Agents for Pancreatic Cancer, Ovarian Cancer, or Liver Cancer Comprising a Novel Water-Soluble Prodrug
RU2439073C1 (ru) * 2010-07-13 2012-01-10 Государственное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" (ГОУ ВПО "КубГТУ") СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНЫХ ИНДОЛИЗИНО[7,6-b]ИНДОЛА
EP3946464B1 (en) 2019-03-29 2022-08-31 MedImmune Limited Compounds and conjugates thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4473692A (en) 1981-09-04 1984-09-25 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
US4939255A (en) * 1987-06-24 1990-07-03 Daiichi Pharmaceutical Co., Ltd. Hexa-cyclic camptothecin derivatives
HU213136B (en) * 1990-08-14 1997-02-28 Kyorin Seiyaku Kk Process for producing fluoroethyl camptothecin derivatives and pharmaceutical compositions containing them
JP3008226B2 (ja) * 1991-01-16 2000-02-14 第一製薬株式会社 六環性化合物
JP3359955B2 (ja) * 1992-07-16 2002-12-24 第一製薬株式会社 抗腫瘍剤
GB9402934D0 (en) * 1994-02-16 1994-04-06 Erba Carlo Spa Camptothecin derivatives and process for their preparation
US5663177A (en) * 1995-05-31 1997-09-02 Smithkline Beecham Corporation Water soluble camptothecin analogs
WO1998035940A1 (en) 1997-02-14 1998-08-20 Bionumerik Pharmaceuticals, Inc. Highly lipophilic camptothecin derivatives
GB9715821D0 (en) * 1997-07-25 1997-10-01 Pharmacia & Upjohn Spa Amidino-camptothecin derivatives

Also Published As

Publication number Publication date
RS47004A (sr) 2007-02-05
HUP0500062A3 (en) 2012-12-28
TWI258481B (en) 2006-07-21
HK1077303A1 (en) 2006-02-10
KR20040062976A (ko) 2004-07-09
EP1480984A2 (en) 2004-12-01
UA80409C2 (en) 2007-09-25
AU2002356720A1 (en) 2003-06-10
US20030144304A1 (en) 2003-07-31
ES2307830T3 (es) 2008-12-01
CA2468824A1 (en) 2003-06-05
MY136138A (en) 2008-08-29
BR0214615A (pt) 2004-09-14
US6825194B2 (en) 2004-11-30
EP1480984B1 (en) 2008-06-11
WO2003045952A3 (en) 2003-10-16
ZA200404522B (en) 2005-01-04
US20050059679A1 (en) 2005-03-17
HUP0500062A2 (hu) 2005-04-28
NZ533568A (en) 2006-01-27
UY27560A1 (es) 2003-05-30
PL370479A1 (en) 2005-05-30
US7109195B2 (en) 2006-09-19
CN1617874A (zh) 2005-05-18
KR100895746B1 (ko) 2009-04-30
JP2005511643A (ja) 2005-04-28
PE20030725A1 (es) 2003-08-28
HK1072935A1 (en) 2005-09-16
TW200408642A (en) 2004-06-01
PL207510B1 (pl) 2010-12-31
CA2468824C (en) 2011-01-11
EP1480984B9 (en) 2009-03-11
PA8558901A1 (es) 2003-06-30
RU2004119841A (ru) 2005-03-27
AU2002356720B2 (en) 2009-01-29
JP4305909B2 (ja) 2009-07-29
ATE398131T1 (de) 2008-07-15
RU2299212C2 (ru) 2007-05-20
NO20042729L (no) 2004-08-27
DE60227113D1 (de) 2008-07-24
GT200200250A (es) 2004-01-15
NO329005B1 (no) 2010-07-19
WO2003045952A2 (en) 2003-06-05
IL162058A0 (en) 2005-11-20
CN100338066C (zh) 2007-09-19
MXPA04005185A (es) 2004-08-11

Similar Documents

Publication Publication Date Title
CA2880739C (en) Piperazinotriazole compound, preparation method thereof, and use thereof in drug preparation
RS55856B1 (sr) Heterociklična jedinjenja agonisti ip receptora
CN116096372A (zh) 一种egfr抑制剂、其制备方法和在药学上的应用
AU2019375825B2 (en) Macrocyclic tyrosine kinase inhibitor and uses thereof
CN116406363B (zh) 四环类衍生物、其制备方法及其医药上的用途
US6268375B1 (en) 10, 11-difluoromethylenedioxycamptothecin compounds with topoisomerase I inhibition
RS51051B (sr) Heksaciklična jedinjenja
US7595400B2 (en) Process for the preparation of hexacyclic compounds
CN112279863A (zh) Hsp90抑制剂与喜树碱衍生物的偶联物及其制备方法与应用
US12076320B2 (en) Diarylpyrazole compound, composition comprising same, and use thereof
HK1072935C (en) Hexacyclic compounds
HK1072935B (en) Hexacyclic compounds
HK1105419A1 (en) Camptothecin derivatives and their uses
HK1105419B (en) Camptothecin derivatives and their uses